Title Category Credit Event date Cost
Medical Advances and Optimal Treatment Approaches for Inflammatory Bowel Disease
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 The Centers for Disease Control (CDC) estimate that 1 to 1.3 million people suffer from inflammatory bowel disease (IBD) in the United States. These patients often require long-term management involving steroids, maintenance therapy with immunomodulators and biologicals, and acute interventions. During this activity, factors affecting the risk and course of IBD and the most updated protocols and guidelines for diagnosing and treating IBD will be discussed. New therapies targeting the immune process that are revolutionizing the treatment of IBD will also be presented.
Chronic Pain Is a Disease, Not a Symptom of Disease
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 When pain becomes chronic, it is no longer merely a symptom, but a disease in itself. According to the National Health Interview Survey, an estimated 25.3 million adults in the United States suffer from chronic pain. This activity will focus on what is new in the management of chronic pain and in what ways this field is evolving. The importance of interprofessional strategies to integrate pharmaceutical and nonpharmaceutical treatment options for chronic pain will be addressed, as well as the importance of improving communication with patients about chronic pain diagnosis and treatment.
Closing the Gap in Health Equity
  • Wellness
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - Ethics
$0.00 In the United States, racial/ethnic minority, rural, and low-income populations continue to experience suboptimal access to and inequity of health care despite decades of recognition of health disparities and policy mandates to eliminate them. There are a number of disease states with recognized disparities and many health care interventions designed to achieve health equity fall short due to gaps in knowledge and translation.
Chronic Kidney Disease: Early and Effective Intervention and Evidence-based Guidelines for Optimal Management
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Chronic kidney disease (CKD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted. It is responsible for premature death and demands a high economic price from both the private and public sectors. The prevalence of CKD is increasing, and more than 50 percent of adults 30–64 years old are projected to develop CKD over their lifetimes.
Primary Care Treatment Strategies for Depression: Childhood Through Young Adulthood
  • Pediatrics
  • AMA
  • ANCC
  • APA
  • Attendance
$0.00 MDD, or clinical depression, affects how you feel, think and behave and can lead to a variety of emotional and physical issues. Although treatment guidelines outline a set of best practices based on the available empirical evidence and there is current clinical consensus, there are still barriers to the appropriate treatment for those suffering from MDD.
Financial Acumen for Physician Leaders
  • AMA
  • Attendance
$0.00 The primary role of finance is to plan for, acquire and utilize resources to maximize efficiency and create value for the organization’s mission. During this activity, the functions of finance in a physician enterprise will be reviewed, including the process for budget preparation. Financial statements, key performance indicators, and key drivers of revenue and expenses will also be discussed.Learning objectives At the end of this educational activity, participants should be able to:
Strategic Business Planning
  • AMA
  • Attendance
$0.00 Strategic and business planning are important tools for guiding health care organizations. Multiple factors influence the health care industry today that will impact physician enterprises going forward. Involving physicians is paramount to successful planning and execution.This activity will focus on strategy development and execution through business planning that allows organizations to identify and address influencing factors and position the physician enterprise for future success.
Have We Achieved Pareto Optimality or Pareto Efficiency in Transplantation
  • Transplantation
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • CCMC - Ethics
$0.00 Pareto optimality is a formally defined concept used to judge the efficiency of a distribution when shared goods or resources are allocated to many. Pareto efficiency occurs when all resources are exhausted, and any change in allocation will make at least one party worse off. During this activity, Dr. Abecassis will discuss similarities and differences between Pareto optimality, equity, and social optimality in order to provide a conceptual framework to better understand the dynamics and behaviors we are currently witnessing in national debates around liver allocation.
Chronic Kidney Disease Continuum: The Relationship Between Obesity, Diabetes, Cardiovascular Disease and Transplant
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Chronic kidney disease (CKD) is associated with an increased risk for cardiovascular disease, progression to end-stage-renal disease (ESRD) and potentially the need for a kidney transplant. This session will explore the relationship between obesity, diabetes, kidney disease, cardiovascular disease and transplant; the challenges of meeting evidence-based guidelines for managing CKD; and the benefits of addressing multiple risk factors simultaneously and the impact on outcomes.
Cardiovascular Disease: Guidelines and Challenges in Patient Management
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 In 2013, the American College of Cardiology (ACC) and the American Heart Association (AHA), developed new guidelines for the treatment of blood cholesterol and risk assessment of atherosclerotic cardiovascular disease (ASCVD). The new guidelines recommend the use of statin therapy as the medication of choice in ASCVD risk reduction. This was a major shift from the old approach, creating controversies and a state of confusion.

Pages